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Abstract
Background: There is growing evidence that maximal surgical resection of primary intrinsic brain tumours is
beneficial, both by improving progression free and overall survival and also by facilitating postoperative
chemotherapy and radiotherapy. Hence, there has been an increase in the popularity of real-time intraoperative
imaging in brain tumour surgery. The complex theatre arrangements, prohibitive cost and prolonged theatre time
of intraoperative MRI have restricted its application. By comparison, intraoperative three-dimensional ultrasound
(i3DUS) is user friendly, cost-effective and portable and adds little to surgical time. However, operator-dependent
image quality and image interpretation remain limiting factors to the wider application of this technique. The aim
of this study was to explore objective i3DUS image analysis and its potential therapeutic role in brain tumour
surgery.
Methods: A prospective, observational study was undertaken (approved by the local Research and Ethics
Committee prior to recruitment). Biopsies were taken from the solid, necrotic, periphery and brain/tumour interface
of intrinsic primary brain tumours. Digital i3DUS images were analysed to extract quantitative parameters from
these regions of interest (ROI) in the i3DUS images. These were then correlated with the histology of the relevant
specimens. The histopathologist was blinded to the imaging findings.
Results: Ninety-seven patients (62 males; mean 54 years) with varying gliomas (84 high grade) were included. Two
hundred and ninety regions of interest were analysed. Mean pixel brightness (MPB) and standard deviation (SD)
were correlated with histological features. Close correlations were noted between MPB and cellularity, and SD and
intrinsic cellular diversity.
Conclusions: MPB and SD are objective measures reflecting the sensitivity of i3DUS in detecting the presence and
extent of intrinsic brain tumours. They indirectly suggest heterogeneity, cellularity and invasiveness, providing
information of the nature of the tumour, and also reflect the sensitivity of intraoperative US to detect the presence
of residual intrinsic brain tumours. Development of this paradigm will enhance i3DUS use as an adjunct in brain
tumour surgery. Optimizing its intraoperative application will impact surgical resection and, hence, patient outcome.
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Background
The prognosis for patients with intrinsic brain tu-
mours remains poor, despite advances in imaging,
surgical technology and adjuvant treatments [1]. Near
total resection of infiltrative neuroepithelial tumours
has been shown to have a positive impact on quality
of life, progression free and overall survival [2–5].
Hence, the capability to achieve maximal resection
has led to an increase in the popularity of intraopera-
tive imaging. This attempts to eliminate the error
produced by brain shift, due to loss of CSF and
tumour resection, an inherent problem of navigation
systems based on preoperative imaging [6].
Intraoperative magnetic resonance imaging (iMRI) re-
quires a customized operative MR suite and specialized
MR compatible surgical instruments, and case duration
is typically prolonged due to the time taken to acquire
the images and patient transfer into and out of the
scanner. However, the images produced by iMRI have
excellent resolution. By comparison, intraoperative
three-dimensional ultrasound (i3DUS) is a portable sys-
tem offering real-time imaging, which does not require
its own dedicated suite. It can be integrated into existing
theatre infrastructure with minimal disruption to surgi-
cal workflow. It allows precise visualization of blood ves-
sels, the ventricular system, lesions and immediate
complications, such as a haematoma. It is also signifi-
cantly cheaper. It has the potential intraoperative thera-
peutic use of facilitating decision-making, not purely
acting as a diagnostic tool. However, ultrasound is user
dependent, with an operator learning curve. Further-
more, image analysis remains an underdeveloped field.
Several neurosurgical centres have employed i3DUS,
with integrated image guidance based on multimodal
preoperative imaging, to achieve maximal safe resections
of brain tumours [7–11]. These systems are able to up-
date a conventional image guidance system based on
preoperative images, with real-time three-dimensional
ultrasound images obtained during surgery. By permit-
ting multiple acquisitions, the frequent update of the
image guidance system facilitates elimination of the in-
accuracy of conventional navigation [6]. Due to variation
in the information contained within each modality, the
correlation of intraoperative ultrasound with preopera-
tive MRI images has been recognized as a challenge.
Various computational methods have been proposed and
tested on animal and phantom models [12]. The accur-
acy of i3DUS navigation to target an area in the brain
has been tested in vitro and recorded as within 2 mm
[13]. This registration error is typical of that reported by
most non-frame-based navigation systems [14] and is
considered acceptable in standard clinical practice for
brain tumour resection where the target is typically far
larger than in functional neurosurgery. However, these
studies were based on subjective interpretation of the
US digital images. No study, prior to this [15], has ex-
plored the maximum potential of i3DUS as an imaging
modality, using objective measures. The aims of this
study, therefore, were to explore objective image analysis
and its potential use in brain tumour surgery and to en-
courage further prospective quantitative studies to assess
the accuracy and sensitivity of i3DUS to detect the true
extent of intrinsic brain tumours, thus facilitating max-
imal resection.
Methods
This was a prospective, observational study. The project
was approved by the Local Research Ethics Committee
of Imperial College Healthcare NHS Trust.
Patients
All patients admitted to the Unit with an intrinsic brain
tumour between March 2009 and November 2013 were
considered for recruitment. Every patient was discussed
in the neuro-oncology multi-disciplinary team (MDT)
meeting, as per the standard tumour protocol. Patients
undergoing biopsy or resection surgery were invited to
participate. Following appropriate discussion, with
provision of written information and suitable time for
consideration, formal informed consent was obtained.
Methods
The operative procedure involved the standard surgical
steps for an infrared navigation system and image-
guided craniotomy. The preoperative volumetric
contrast-enhanced brain scan (MRI or CT), undertaken
with scalp fiducials, was stored in digital format and
transferred onto the SonoWand workstation (Trademark
registered by the SonoWand Company Trondheim,
Norway). This navigation system offers the ability to up-
date the navigation data with sequential i3DUS sweeps
taken before the dura is opened and at several stages
during a biopsy/debulking procedure. Intraoperative
3DUS-guided biopsies were taken using a biopsy needle
with a custom-made reference frame capable of being
tracked by the SonoWand camera (a Hennig needle;
Elekta). The biopsies were taken from the solid region
and the periphery of the tumour and the tumour/brain
interface. For high-grade lesions, they were taken from
the solid and necrotic areas of each tumour and the
tumour/brain interface. All biopsies were undertaken
following the dural opening, prior to tumour resection.
The exact site for each sample was determined at the
time of the procedure by the two operating surgeons,
using the preoperative scan combined with the intraop-
erative 3DUS image. To minimize error, the biopsies
were taken prior to any resection, to ensure that the
architecture of the tumour was unchanged at the time of
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sampling. For reference, digital images of the biopsy nee-
dle position were taken at the time of each biopsy. The
specimens were subsequently examined by a histopath-
ologist blinded to the imaging findings.
Image analysis was undertaken using ImageJ [16]. A
region of interest (ROI) was defined as the area in the
digital image around the opening of the biopsy needle at
the time of sampling. This accommodated the distance
of the aperture from the tip of the biopsy needle and
was calculated to reflect the area of the image directly
adjacent to the sampling site of the biopsy needle. The
ROI comprised 468 pixels, which were then analysed
using a brightness intensity scale (range 0–255). Mean
pixel brightness (MPB) and the standard deviation (SD)
of the MPB were obtained from each ROI. Further data
analyses were undertaken using SPSS Statistics
(Trademark registered by SPSS Statistics) and Sofastats,
open-source statistical package (Trademark registered by
Paton-Simpson & Associates).
Results
Ninety-seven patients who underwent biopsy or debulk-
ing surgery were included in the analyses. There were 62
male and 35 female patients, with a mean age of
54.3 years (median 56 years). The histological diagnosis
of each analysed patients is presented in Table 1.
Two hundred ninety ROIs were identified as previ-
ously detailed. There were three ROIs per patient, with
the exception of the single patient with a pilocytic astro-
cytoma, where only two ROIs were analysed. The yield
of biopsy was 100%, that is, all biopsies undertaken using
i3DUS guidance produced pathological specimens. Fur-
thermore, the samples’ descriptive histological features
corresponded to the region from which they were se-
lected (solid/necrotic/periphery/interface).
The ultrasound gain settings used at the time of image
acquisition affect the absolute values of the brightness
intensity. No attempt was made to normalize the data to
account for this, as obtaining maximum image quality
was considered key, and the pattern of distribution of
the pixel brightness was found to be independent of the
gain setting, as demonstrated in Fig. 1.
Analysis of the 290 ROIs in the vicinity of the opening of
the biopsy needle revealed a close correlation between the
histological features of the tumours and MPB and its SD.
There were also repeated recognizable patterns and char-
acteristic of different types of tumours, as detailed below.
1) Glioblastoma multiforme World Health
Organization (WHO) grade IV
In the 68 WHO grade IV patients, there were
varying MPB and SD for the solid, necrotic and
infiltrating interface of the tumour with the brain
(Fig. 2), which were demonstrated to be statistically
Table 1 Histological diagnoses of the patient group
Tumour type Number of patients (%)
Pilocytic astrocytoma 1 (1.0)
Diffuse astrocytoma (WHO grade II) 2 (2.1)
Oligoastrocytoma (WHO grade II) 1 (1.0)
Oligodendroglioma (WHO grade II) 9 (9.4)
Anaplastic astrocytoma (WHO grade III) 6 (6.2)
Oligoastrocytoma (WHO grade IIII) 1 (1.0)
Oligodendroglioma (WHO grade III) 6 (6.2)
Glioblastoma multiforme (WHO grade IV) 67 (69.1)
Glioblastoma with previous radiotherapy 1 (1.0)
Gliomatosis cerebri 3 (3.1)
Fig. 1 The pattern of distribution of pixel brightness at varying gain
settings. The pattern of distribution of the pixel brightness was
independent of the gain setting
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significantly different (Table 2). Interestingly, in 27
(39.7%) of these patients, a different pattern was
noted, where the solid component showed a
relatively low MPB and unusually high SD.
2) Anaplastic astrocytomas WHO grade III
In six anaplastic astrocytoma patients, biopsies were
obtained from the core, that is the area of the
highest echogenicity, the periphery and the tumour
interface (Table 3; Fig. 3). When compared to the
WHO grade IV tumours, anaplastic astrocytomas
were generally found to have a low MPB at the core.
At the interface with the brain, they were found to
have a similar MPB.
3) Grade II oligodendroglioma with areas of anaplastic
transformation
In 6 of the 15 oligodendroglioma patients,
anaplastic transformation was observed. In the
representative case shown in Fig. 4, the
preoperative scan revealed areas of enhancement.
Biopsies were taken from the low echogenicity
area, high echogenicity areas and the tumour/
brain interface. The high echogenicity areas with
the highest MPB correlated to the areas of
malignant transformation (Table 4).
4) Infiltrative astrocytomas WHO grade II
Low-grade infiltrative astrocytomas were found to
have consistently lower MPB in the centre and
periphery (85.8 and 77.8, respectively). The MPB at
the interface of the low-grade infiltrative astrocyto-
mas was 61.5.
5) Pilocytic astrocytomaWHO grade I
The analysis of one pilocytic astrocytoma showed
the interface SD lower than the core SD of the
tumour. Table 5 details the MPB and SD.
To explore the specificity of i3DUS, the imperial
tumour index (ITI) was computed (MPB/SD of that
MPB). The ITI was proportional to cellularity and was
raised in solid areas of high-grade tumours, as detailed
in Table 6.
The infiltration index was also calculated as the ratio
of the SD of the core or solid component MPB: the SD
of the interface MPB. The infiltration index (II) was
found to be less than 1 in infiltrative tumours and higher
than 1 in noninfiltrative tumours, that is, the pilocytic
astrocytoma (Table 7).
Discussion
This prospective study has provided preliminary data
of i3DUS image analysis. Several studies have already
demonstrated the benefits of intraoperative real-time
US for achieving maximal safe resection in brain
tumour surgery [7–11]. This study succeeds previous
work, showing the use of objective image analysis in
determining the presence and the extent of intrinsic
Fig. 2 An example of the digital ultrasound images obtained from a WHO grade IV lesion. Biopsies were taken from the solid (a) and nectrotic
(b) regions and the infiltrating interface (c) of a WHO grade IV lesion. On these ultrasound images, the blue line represents the biopsy needle,
whilst the yellow circle is the tip, with a projected tip extension shown beyond the tip/yellow circle
Table 2 MPB and its characteristics for the 68 patients with
WHO grade IV tumours
MPB 95% confidence intervals SD Minimum Maximum
Solid 188.8 187.8–189.9 11.6 152.0 213.0
Necrotic 123.2 121.8–124.6 15.2 81.0 168.0
Interface 70.8 69.4–72.2 15.4 38.0 105.0
Paired t test of MPB: p < 0.001 (solid versus necrotic; solid versus interface)
Table 3 MPB and its characteristics for the six patients with
WHO grade III tumours
MPB 95% confidence intervals SD Minimum Maximum
Core 166.7 165.6–167.8 12.2 126.0 208.0
Periphery 120.2 119.1–121.3 12.1 94.0 148.0
Interface 83.3 82.1–84.5 13.0 45.0 131.0
Paired t test of MPB: p < 0.001 (core versus periphery; periphery
versus interface)
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brain tumours, which has the potential to guide re-
section. A close correlation between the histological
features of intrinsic primary brain tumours and MPB
and its SD is reported, with recognizable patterns and
characteristic of different types of tumours.
MPB objectively quantifies echogenicity and SD het-
erogeneity. The solid part of high-grade gliomas was
found to have the highest MPB, whilst lower MPB
readings were observed at the necrotic core of the tu-
mours. Low MPB values were also consistently ob-
served at the infiltrating margins of the tumours. SD
was higher at the infiltrating margins of the high-
grade tumours. It was also elevated within the same
tumours in areas of varying cellularity and within
solid high-grade gliomas (WHO grade IV) with
impending necrosis. A possible explanation for these
observations is that these different cell types produce
a heterogenous population. This intrinsic diversity is
reflected in the tissues’ physical properties, with vary-
ing echogenic characteristics, which are visualized by
US. In comparison, hypercellular regions, such as the
solid part of high-grade glioma WHO grade IV, com-
prise densely packed homogenous malignant cells
(hence, the high MPB) and relatively low SD.
This preliminary work has shown MPB as a surro-
gate measure of tissue density, which in turn is a sen-
sitive indicator of cellularity, and SD as a measure of
cellular diversity. US is a mechanical wave which is
altered as it travels through tissue (attenuation, ab-
sorption, refraction, reflection). It is very sensitive at
detecting pathology which alters the physical proper-
ties of the brain parenchyma, even if these changes
are very modest. The use of image analysis in this
study eliminated the subjective interpretation of US
Fig. 3 Graphic representation of MPB in the six patients with an anaplastic astrocytoma (WHO grade III). The MPB was highest at the core and
lowest at the interface
Fig. 4 An example of an oligodendroglioma with a transformed region. The transformed region is demonstrated by the enhancement on the
navigation T1 with contrast MRI (movement artefact of the patient) (a) and the corresponding hyperechogenic area on the i3DUS image (b). On
these images, the navigation tool is represented by the blue line and its tip by the yellow circle. The projected tip extension is shown as a
continuation of this line
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and demonstrated the sensitivity of i3DUS in identify-
ing regions of higher cellularity within intrinsic brain
tumours and their extent. This may be of particular
use in low-grade gliomas. The US data may also be
able to demonstrate necrosis before it is apparent on
CT/MRI brain scans. Furthermore, SD at the margins
of a lesion, when sampled and analysed in real time,
may provide the surgeon with information regarding
a possible surgical plane. These findings illustrate the
application of i3DUS and its potential therapeutic use
during surgical resection.
The ITI attempted to quantify the differences in the
distribution of MPB, which were then assessed in re-
lation to tissue type. ITI was highest in solid regions
of high-grade lesions but was not found to be specific
for different tumour types. The infiltration index was
inversely related to the infiltrative potential of the
tumour type. The lowest infiltration indices were ob-
served in grade IV lesions, with that greater than 1 in
the lesion with no infiltrative potential. This is again
a preliminary work on a relatively small data set and
requires further development. The role of 5-
aminolevulinic acid in high-grade tumours and intra-
operative MRI in low-grade lesions are acknowledged,
and with augmentation, i3DUS is not envisaged as an
alternative. However, it is hoped that further develop-
ment of this field will expand the armamentarium of
the neurosurgeon.
In this study, patients with suboptimal imaging were
excluded, which created a bias. However, the aim of
this study was to provide preliminary image analysis
data, and therefore, only the highest quality images
were selected. The careful choice of targets and the
exclusion of data, where there was any uncertainty of
the clarity of the imaging, aided the avoidance of
artefacts.
Image analysis was undertaken using ImageJ, a
Java-based open source software, which has been val-
idated in image analysis for electron microscopy in
microbiology, genetics and more recently in the ana-
lysis of images taken by powerful telescopes in as-
tronomy [16]. MPB is an established measure to
quantify echogenicity, which in turn is representative
of the characterization of the parenchyma [17, 18].
Indeed, relative pixel brightness has been used as an
objective parameter for the quantification of the
echogenicity of ROIs in neonatal brains [19].
The results from the current study are significant in
the context of the growing evidence that the extent of
resection of intrinsic brain tumours impacts clinical out-
come [2–5]. Hence, there is a role for highly sensitive,
accurate and affordable intraoperative guidance. Arte-
facts are an acknowledged limitation of US imaging [20].
They are more prominent in tumour resection due to
the mirroring/shadowing effect of the tumour cavity.
This may be overcome by modern, smaller probes which
can be introduced into the surgical cavity, permitting
scanning of the walls. The direct contact may minimize
such artefacts. Furthermore, a profile of the characteris-
tics of such artefacts will be gathered over time.
Table 4 MPB and its characteristics for the six patients with oligodendroglioma and areas of anaplastic transformation
MPB 95% confidence intervals SD Minimum Maximum
WHO grade II region 122.2 121.0–123.4 13.5 88.0 162.0
Transformed region 182.2 182.2–183.7 16.9 123.0 228.0
Interface 31.5 30.2–32.7 14.1 10.0 110.0
Paired t test of MPB: p < 0.001 (grade II versus transformed; grade II versus interface)
Table 5 MPB and its characteristics for the patient with a
pilocytic astrocytoma
MPB 95% confidence intervals SD Minimum Maximum
Core 124.5 123.2–125.8 14.1 94.0 168.0
Interface 38.1 37.1–39.2 11.5 20.0 78.0
Paired t test of MPB: p < 0.001 (core versus interface)
Table 6 The imperial tumour index for the different tissue types
MPB SD ITI
Grade IV solid 188.8 11.6 16.3
Grade IV necrotic 123.2 15.2 8.1
Grade IV interface 70.8 15.4 4.6
Grade III core 166.7 12.2 13.7
Grade III periphery 120.2 12.1 9.9
Grade III interface 83.3 13.0 6.4
Grade II astrocytoma core 85.8 10.3 8.3
Grade II astrocytoma periphery 77.8 11.4 6.8
Grade II astrocytoma interface 61.5 10.4 5.9
Oligodendroglioma transformed 182.2 16.9 10.8
Oligodendroglioma grade II 122.2 13.5 9.1
Oligodendroglioma interface 31.5 14.1 2.2
Pilocytic astrocytoma core 124.5 14.1 8.8
Pilocytic astrocytoma interface 38.1 11.5 3.3
Camp et al. Journal of Therapeutic Ultrasound  (2017) 5:2 Page 6 of 8
Conclusions
Historically, the use of i3DUS for brain tumour surgery
has suffered from a lack of objective image interpret-
ation. This study aimed to address the matter by provid-
ing preliminary data. This work demonstrated the ability
of i3DUS to detect the presence and distinct properties
of intraparenchymal brain tumours, with close correla-
tions between imaging characteristics and histological
features. Based on the findings of this prospective study,
there is potential to further advance i3DUS with sophis-
ticated image analysis techniques, in order to achieve af-
fordable, reliable, portable, user-friendly, real-time,
intraoperative image guidance and analyses which will
promote the therapeutic option of surgery in the treat-
ment of brain tumours.
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